Bergs Securities acted as financial adviser and sole bookrunner to Medclair in its SEK 23 million directed share issue to Eiffel Investment Group

Bergs Securities is proud to have acted as financial adviser and sole bookrunner to Medclair in its SEK 23 million directed share issue to Eiffel Investment Group.

Medclair is a Swedish cleantech company and a leader in safe and sustainable nitrous oxide management. Operating in twenty countries, Medclair offers innovative solutions that significantly reduce the climate impact of nitrous oxide while simultaneously improving the working environment.

Eiffel Investment Group is a French asset manager with approximately EUR 7 billion in assets under management, focusing on investments in growth companies and the energy transition. Eiffel has a strong sustainability focus and invests through private debt, energy‑transition infrastructure, private equity, and listed equities and credit. Furthermore, Eiffel is an active investor in listed Swedish growth companies.